4.5 Article

The focal adhesion targeting domain of p130Cas confers a mechanosensing function

Journal

JOURNAL OF CELL SCIENCE
Volume 130, Issue 7, Pages 1263-1273

Publisher

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/jcs.192930

Keywords

Focal adhesion; Mechanosensing; NEDD9; P130Cas; FAT; Cell migration

Categories

Funding

  1. New South Wales Cancer Council (Cancer Council NSW) [RG12/06]
  2. University of Sydney Strategic Priority Areas through Dooley's Lidcombe Catholic Club
  3. University of Sydney postgraduate student scholarship
  4. German Academic Exchange Service award (Deutscher Akademischer Austauschdienst)
  5. C4-fellowship from the Kids Cancer Project

Ask authors/readers for more resources

Members of the Cas family of focal adhesion proteins contain a highly conserved C-terminal focal adhesion targeting (FAT) domain. To determine the role of the FAT domain in these proteins, we compared wild-type exogenous NEDD9 with a hybrid construct in which the NEDD9 FAT domain had been exchanged for the p130Cas (also known as BCAR1) FAT domain. Fluorescence recovery after photobleaching (FRAP) revealed significantly slowed exchange of the fusion protein at focal adhesions and significantly slower two-dimensional migration. No differences were detected in cell stiffness as measured using atomic force microscopy (AFM) and in cell adhesion forces measured with a magnetic tweezer device. Thus, the slowed migration was not due to changes in cell stiffness or adhesion strength. Analysis of cell migration on surfaces of increasing rigidity revealed a striking reduction of cell motility in cells expressing the p130Cas FAT domain. The p130Cas FAT domain induced rigidity dependent phosphorylation of tyrosine residues within NEDD9. This in turn reduced post-translational cleavage of NEDD9, which we show inhibits NEDD9-induced migration. Collectively, our data therefore suggest that the p130Cas FAT domain uniquely confers a mechanosensing function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer

Loretta M. S. Lau, Chelsea Mayoh, Jinhan Xie, Paulette Barahona, Karen L. MacKenzie, Marie Wong, Alvin Kamili, Maria Tsoli, Tim W. Failes, Amit Kumar, Emily V. A. Mould, Andrew Gifford, Shu-Oi Chow, Mark Pinese, Jamie Fletcher, Greg M. Arndt, Dong-Anh Khuong-Quang, Carol Wadham, Georgina Eden, Peter Trebilcock, Swapna Joshi, Stephanie Alfred, Anjana Gopalakrishnan, Aaminah Khan, Dylan Grebert Wade, Patrick A. Strong, Elodie Manouvrier, Lisa T. Morgan, Roxanne Cadiz, Caitlin Ung, David M. Thomas, Katherine M. Tucker, Meera Warby, Geoffrey B. McCowage, Luciano Dalla-Pozza, Jennifer A. Byrne, Federica Saletta, Andrew Fellowes, Stephen B. Fox, Murray D. Norris, Vanessa Tyrrell, Toby N. Trahair, Richard B. Lock, Mark J. Cowley, Paul G. Ekert, Michelle Haber, David S. Ziegler, Glenn M. Marshall

Summary: The study developed a precision medicine platform involving rapid high-throughput drug screening and patient-derived xenografting for high-risk pediatric cancer patients. Results showed that 70% of patients across the entire testing platform were able to find treatment options, with some patients experiencing clinical benefits after changes in treatment plans.

EMBO MOLECULAR MEDICINE (2022)

Article Cell Biology

Plectin-mediated cytoskeletal crosstalk controls cell tension and cohesion in epithelial sheets

Magdalena Prechova, Zuzana Adamova, Anna-Lena Schweizer, Miloslava Maninova, Andreas Bauer, Delf Kah, Samuel M. Meier-Menches, Gerhard Wiche, Ben Fabry, Martin Gregor

Summary: This study reveals the crucial role of plectin in supporting intercellular junctions through organizing cortical cytoskeletal networks in epithelial sheets. Deficiency of plectin leads to abnormal cytoarchitecture, elevated intracellular tension, and reduced intercellular cohesion, resulting in destabilization of tissues under mechanical stress.

JOURNAL OF CELL BIOLOGY (2022)

Meeting Abstract Oncology

NOVEL PAEDIATRIC CASE OF A SPINAL HIGH-GRADE ASTROCYTOMA WITH PILOID FEATURES IN A PATIENT WITH NOONAN SYNDROME

Jordan Staunton, Pamela Ajuyah Robertson, Angela Harris, Chelsea Mayoh, Marie Wong, Megan Rumford, Noemi Fuentes-Bolanos, Mark Cowley, Loretta Lau, David S. Ziegler, Paulette Barahona, Neevika Manoharan

NEURO-ONCOLOGY (2023)

Article Multidisciplinary Sciences

Directionality of developing skeletal muscles is set by mechanical forces

Kazunori Sunadome, Alek G. G. Erickson, Delf Kah, Ben Fabry, Csaba Adori, Polina Kameneva, Louis Faure, Shigeaki Kanatani, Marketa Kaucka, Ivar Dehnisch Ellstroem, Marketa Tesarova, Tomas Zikmund, Jozef Kaiser, Steven Edwards, Koichiro Maki, Taiji Adachi, Takuya Yamamoto, Kaj Fried, Igor Adameyko

Summary: The developing skeleton produces mechanical tension that guides the directional outgrowth of skeletal muscles. Formation of oriented myofibrils is crucial in musculoskeletal development. The mechanisms that control myocyte orientation and fusion for muscle directionality in adults are still unknown.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes

Pamela Ajuyah, Chelsea Mayoh, Loretta M. S. Lau, Paulette Barahona, Marie Wong, Hazel Chambers, Fatima Valdes-Mora, Akanksha Senapati, Andrew J. Gifford, Colleen D'Arcy, Jordan R. Hansford, Neevika Manoharan, Wayne Nicholls, Molly M. Williams, Paul J. Wood, Mark J. Cowley, Vanessa Tyrrell, Michelle Haber, Paul G. Ekert, David S. Ziegler, Dong-Anh Khuong-Quang

Summary: This study reports a new subtype of midline gliomas with similar features to DMG but lacking the H3K27M mutation. These tumors have recurrent mutations in ACVR1 or EGFR and high expression of EZHIP. They have a poor prognosis similar to H3K27M DMG and exhibit distinct transcriptome and methylome profiles. The study provides new insights into the mechanism and pathway regulation of these tumors, potentially opening new therapeutic avenues.

SCIENTIFIC REPORTS (2023)

Article Medicine, General & Internal

Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT study

Noemi Auxiliadora Fuentes Bolanos, Bhavna Padhye, Macabe Daley, Jacqueline Hunter, Kate Hetherington, Meera Warby, Eliza Courtney, Judy Kirk, Sarah Josephi-Taylor, Yuyan Chen, Frank Alvaro, Kristine Barlow-Stewart, Marie Wong-Erasmus, Paulette Barahona, Pamela Ajuyah, Ann-Kristin Altekoester, Vanessa J. Tyrrell, Loretta M. S. Lau, Claire Wakefield, Dianne Sylvester, Katherine Tucker, Mark Pinese, Luciano Dalla Pozza, Tracey A. O'Brien

Summary: The PREDICT study aims to identify germline cancer predisposition (CP) in children with cancer through trio whole-genome sequencing (trio WGS) and evaluate its clinical utility and psychosocial impact. The study will assess heritability by analyzing biological parents and examine the psychosocial impact of trio sequencing. This research will help inform the integration of comprehensive testing into the standard care of childhood cancer patients at diagnosis.

BMJ OPEN (2023)

Article Genetics & Heredity

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer

Chelsea Mayoh, Andrew J. Gifford, Rachael Terry, Loretta M. S. Lau, Marie Wong, Padmashree Rao, Tyler Shai-Hee, Federica Saletta, Dong-Anh Khuong-Quang, Vicky Qin, Marion K. Mateos, Deborah Meyran, Katherine E. Miller, Aysen Yuksel, Emily V. A. Mould, Rachel Bowen-James, Dinisha Govender, Akanksha Senapati, Nataliya Zhukova, Natacha Omer, Hetal Dholaria, Frank Alvaro, Heather Tapp, Yonatan Diamond, Luciano Dalla Pozza, Andrew S. Moore, Wayne Nicholls, Nicholas G. Gottardo, Geoffrey McCowage, Jordan R. Hansford, Seong-Lin Khaw, Paul J. Wood, Daniel Catchpoole, Catherine E. Cottrell, Elaine R. Mardis, Glenn M. Marshall, Vanessa Tyrrell, Michelle Haber, David S. Ziegler, Orazio Vittorio, Joseph A. Trapani, Mark J. Cowley, Paul J. Neeson, Paul G. Ekert

Summary: By combining immunohistochemistry, RNA sequencing, and whole-genome sequencing, we identified a novel 15-gene immune signature, IPASS, associated with CD8(+) T-cell infiltration in high-risk paediatric cancers. Using this signature, we estimated that up to 31% of high-risk cancers exhibit infiltrating T-cells. Furthermore, we found that PD-L1 protein expression is poorly correlated with PD-L1 RNA expression, and neoantigen load and TMB are not predictive of T-cell infiltration in paediatric cancers.

GENOME MEDICINE (2023)

Article Physics, Applied

Predicting Cell Stress and Strain during Extrusion Bioprinting

Sebastian J. Mueller, Ben Fabry, Stephan Gekle

Summary: Bioprinting of living cells can lead to shape deformations, affecting cell survival and functionality. Extensional stresses occurring when cells leave the nozzle have been ignored. Lattice Boltzmann simulations and a finite-element based cell model were used to study cell deformation inside the nozzle and at its exit. Two simple methods were developed to predict maximum cell stress and approximate cell strains based on printing parameters.

PHYSICAL REVIEW APPLIED (2023)

Review Engineering, Biomedical

The role of biomechanical factors in models of intervertebral disc degeneration across multiple length scales

Daniela Lazaro-Pacheco, Mina Mohseni, Samuel Rudd, Justin Cooper-White, Timothy Patrick Holsgrove

Summary: Low back pain is a major cause of disability worldwide and puts a significant socioeconomic burden on healthcare systems. Intervertebral disc degeneration is a primary cause of lower back pain, and despite the development of regenerative therapies, there are currently no commercially available devices or therapies for disc regeneration. Various models for mechanical stimulation and preclinical evaluation have been developed, but challenges and compromises remain.

APL BIOENGINEERING (2023)

Article Oncology

Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives

Claire E. Wakefield, Kate Hetherington, Eden G. Robertson, Mark W. Donoghoe, Jacqueline D. Hunter, Janine Vetsch, Jonathan M. Marron, Katherine M. Tucker, Glenn M. Marshall, Alexander Broom, Michelle Haber, Vanessa Tyrrell, David Malkin, Loretta Lau, Marion K. Mateos, Tracey A. O'Brien, David S. Ziegler

Summary: Parents and patients rarely regretted participating in a childhood cancer precision medicine trial, even when their hopes were not fulfilled. Most participants found the trial beneficial and expressed high satisfaction.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine

Jessica M. Gereis, Kate Hetherington, Eden G. Robertson, Rebecca Daly, Mark W. Donoghoe, David S. Ziegler, Glenn M. Marshall, Loretta M. S. Lau, Jonathan M. Marron, Claire E. Wakefield

Summary: This study investigated the understanding of parents and adolescent patients participating in a precision medicine clinical trial for childhood cancer. The majority of parents were satisfied with the information materials but had low actual understanding of precision medicine. The study suggests the need for improving the language and format of the materials and providing targeted information resources to enhance understanding of precision medicine.

CANCER (2023)

Article Oncology

High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

Chelsea Mayoh, Jie Mao, Jinhan Xie, Gabor Tax, Shu-Oi Chow, Roxanne Cadiz, Karina Pazaky, Paulette Barahona, Pamela Ajuyah, Peter Trebilcock, Angela Malquori, Kate Gunther, Anica Avila, Doo Young Yun, Stephanie Alfred, Anjana Gopalakrishnan, Alvin Kamili, Marie Wong, Mark J. Cowley, Sophie Jessop, Loretta M. S. Lau, Toby N. Trahair, David S. Ziegler, Jamie I. Fletcher, Andrew J. Gifford, Maria Tsoli, Glenn M. Marshall, Michelle Haber, Vanessa Tyrrell, Timothy W. Failes, Greg M. Arndt, Richard B. Lock, Paul G. Ekert, M. Emmy M. Dolman

Summary: One-third of pediatric cancer patients enrolled in precision medicine programs do not receive therapeutic recommendations from molecular profiling. In order to find potential strategies for treating high-risk pediatric patients, a study conducted in vitro screening of 125 patient-derived samples against a library of 126 anticancer drugs. The results showed that high-throughput drug screening (HTS) can identify effective biomarker-driven therapeutic strategies for high-risk pediatric cancers.

CANCER RESEARCH (2023)

Article Health Care Sciences & Services

Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial

Rebecca Daly, Kate Hetherington, Emily Hazell, Bethany R. Wadling, Vanessa Tyrrell, Katherine M. Tucker, Glenn M. Marshall, David S. Ziegler, Loretta Lau, Toby N. Trahair, Tracey A. O'Brien, Kiri Collins, Andrew J. Gifford, Michelle Haber, Mark Pinese, David Malkin, Mark J. Cowley, Jonathan Karpelowsky, Donna Drew, Chris Jacobs, Claire E. Wakefield

Summary: Precision medicine programs aim to identify personalized treatments for children with cancer, but the various professional groups involved in delivering these programs are understudied. This study explored the experiences of professionals involved in Australia's first precision medicine trial for children with poor-prognosis cancer. The professionals expressed both complexity in their roles and positive views about the impact of precision medicine on their profession.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Meeting Abstract Oncology

True bench-to-bedside science: An international pilot study modeling hard-to-cure pediatric cancers to prioritize therapeutic intervention

Nadine Azzam, Nicole Melong, Lissandra Tuzi, Lisa Pinto, Jamie I. Fletcher, Alvin Kamili, Biljana Dumevska, Loretta Lau, Jennifer A. Chan, Donna L. Senger, Stephanie A. Grover, Michelle Haber, David Malkin, Jason N. Berman

CANCER RESEARCH (2023)

Meeting Abstract Oncology

THE PATHOLOGIC FEATURES OF RELAPSED BRAF-V600E LANGERHANS CELL HISTIOCYTOSIS WITH A CD163 PHENOTYPE

Lara Berklite, Andrew Gifford, Derrick Lian, Loretta Lau, Adam Nelson, Robert Lorsbach, Somak Roy, Ashish Kumar, Jennifer Picarsic

PEDIATRIC BLOOD & CANCER (2023)

No Data Available